Diabetes Drug R&D Services ace

Inquiry

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest In Vitro ADME Profiling of Antidiabetic Drugs
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

In Vitro ADME Profiling of Antidiabetic Drugs

In vitro ADME data are invaluable for enhancing the efficiency of novel antidiabetic drug discovery and minimizing the risk of late-stage development failures. Ace Therapeutics provides comprehensive in vitro ADME analysis services to pave the way for optimal antidiabetic drug discovery and development. With an in-depth understanding of the critical role that ADME properties play in drug success, we offer a range of absorption, distribution, metabolism, and excretion tests to meet the unique needs of our clients' antidiabetic drug discovery programs.

Why is In Vitro ADME Profiling of Antidiabetic Drugs Important?

The development of antidiabetic drugs is currently facing several challenges, including a high failure rate, increasing costs, and delays. In vitro, ADME analysis plays a crucial role in the screening and optimization of candidate drugs. In the early stages of drug research and development, in vitro ADME analysis can screen many candidate drugs quickly and effectively. By simulating the in vivo environment and studying the ADME characteristics of drugs, we can predict how they will behave in the body, enabling us to screen out candidate drugs with good pharmacokinetic characteristics.

Our In Vitro ADME Profiling of Antidiabetic Drugs

Ace Therapeutics leverages extensive expertise in in vitro ADME and a well-established assay technology platform to provide the following assay services for our clients' antidiabetic drug development.

Physicochemical properties	Kinetic and thermodynamic solubility LogD pKa Chemical stability
Metabolic stability	Hepatocyte Stability Hepatic microsomal stability Recombinant CYP450 enzyme stability Hepatic S9 stability Intestinal microsomal stability Plasma stability Whole blood stability
Permeability assessment	Parallel artificial membrane permeation model (PAMPA) Caco-2 cells MDR1-MDCK cells
Distribution	Plasma protein binding Microsomal protein binding Tissue protein binding Blood-plasma ratio (Cb/Cp) Red blood cell-plasma ratio (CRBC/Cp)
Exocytosis and uptake of transporter proteins (substrate and inhibitor assessment)	P-gp/Caco-2 cells BCRP/Caco-2 cells MDR1-MDCK cells OATP1B1, OATP1B3, OAT1, OAT3, OCT1, OCT2, MATE1, MATE2K/HEK293 cells
Drug-drug interactions	CYP450 inhibition CYP450 time-dependent inhibition Evaluation of CYP450 induction using cryopreserved hepatocytes (human, rat, mouse)
Metabolite identification and analysis	Metabolite identification in liver microsomes and other in vitro metabolic reaction systems Metabolite identification in plasma and other fluids or tissues in PK or TK studies Reactive metabolite GSH capture Metabolite production, isolation, purification and structure determination by in vitro or in vivo metabolic reaction systems
Response phenotype	CYP450 reaction phenotyping UGT response phenotyping

Features of Our In Vitro ADME Services

Comprehensive types of molecular assays: We can perform in vitro ADME analysis of different types of antidiabetic drugs such as small molecules, peptides, nucleic acids, antibodies, etc.
Customized services: Flexible experimental design, tailor-made plans according to specific requirements.
Data analysis: Professional interpretation and strong confidentiality of information.

Ace Therapeutics is committed to providing efficient, comprehensive in vitro ADME analysis services to improve the success of antidiabetic drug candidates. Please contact us for more details. We will customize your study to meet your unique drug development needs.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Services

In Vivo Pharmacokinetic Profiling of Antidiabetic Drug